G-CSF induces a potentially tolerant gene and immunophenotype profile in T cells in vivo

Clinical Immunology

Volumn 132, Issue 1, 2009, Pages 83-92

  Toh, Han C ^a   Sun, Li ^b   Soe, Yatanar ^a   Wu, Yonghui ^a   Phoon, Yee P ^a   Chia, Whay K ^a   Wu, Jeanie ^a   Wong, Kee Y ^d   Tan, Patrick ^c,d  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

G CSF; Immune tolerance; T cells; Th17; Treg

Indexed keywords

CD45RO ANTIGEN; CHEMOKINE RECEPTOR CCR6; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 23 RECEPTOR; MESSENGER RNA; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELL LEVEL; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOTOXICITY; DNA FINGERPRINTING; DONOR; DOWN REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOPHENOTYPING; IN VIVO CULTURE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; NORMAL HUMAN; PATHOPHYSIOLOGY; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; TH2 CELL; UPREGULATION;

BLOOD DONORS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CLUSTER ANALYSIS; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-17; RECEPTORS, RETINOIC ACID; RECEPTORS, THYROID HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES; T-LYMPHOCYTES, HELPER-INDUCER; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH2 CELLS;

EID: 67349114808     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.03.509     Document Type: Article

References (43)

1. Zeng D., Dejbakhsh-Jones S., and Strober S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation. Blood 90 (1997) 453-463
2. Rutella S., Pierelli L., Bonanno G., Sica S., Ameglio F., Capoluongo E., Mariotti A., Scambia G., d'Onofrio G., and Leone G. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100 (2002) 2562-2571
3. Rutella S., Zavala F., Danese S., Kared H., and Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J. Immunol. 175 (2005) 7085-7091
4. Sloand E.M., Kim S., Maciejewski J.P., Van Rhee F., Chaudhuri A., Barrett J., and Young N.S. Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo. Blood 95 (2005) 2269-2274
5. Rutella S., Bonnano G., Pierelli L., Mariotti A., Capoluongo E., Contemi A.M., Ameglio F., Curti A., De Ritis D.G., Voso M.T., Perillo A., Mancuso S., Scambia G., Lemoli R.M., and Leone G. Granulocyte colony-stimulating factor promotes the generation of regulatory DC through induction of IL-10 and IFN-alpha. Eur. J. Immunol. 34 (2004) 1291-1302
6. Franzke A., Piao W., Lauber J., Gatzlaff P., Konecke C., Hansen W., Schmitt-Thomsen A., Hertenstein B., Buer J., and Ganser A. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102 (2003) 734-739
7. Buzzeo M.P., Yang J., Casella G., and Reddy V. Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis. Exp. Hematol. 35 (2007) 1456-1465
8. Chen Z., Laurence A., and O'Shea J.J. Signal transduction pathways and transcriptional regulation in the control of Th17 differentiation. Semin. Immunol. 19 (2007) 400-408
9. Bettelli E., Oukka M., and Kuchroo V.K. Th17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8 (2007) 345-350
10. Ivanov I.I., Mckenzie B.S., Zhou L., Tadokoro C.E., Lepelley A., Lafaille J.J., Cua D.J., and Littman D.R. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126 (2006) 1121-1133
11. Langrish C.L., Chen Y., Blumenschein W.M., Amttson J., Basham B., Sedgwick J.D., McClanahan T., Kastelein R.A., and Cau D.J. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 210 (2005) 233-240
12. Acosta-Rodriguez E.V., Napolitani G., Lanzavecchia A., and Sallusto F. Interleukins 1B and 6 but not transforming growth factor-b are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8 (2007) 942-949
13. Wang R.F. Regulatory T cells and toll-like receptors in cancer therapy. Cancer Res. 66 (2006) 4987-4990
14. Peng G., Guo Z., Kiniwa Y., Voo K.S., Peng W., Fu T., Wang D.Y., Li Y., Wang H.Y., and Wang R.F. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 309 (2005) 1380-1384
15. Liu C.Y., Battaglia M., Lee S.H., Sun Q.H., Aster R.H., and Visentin G.P. Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells. J. Immunol. 174 (2005) 2680-2686
16. Agenes F., Bosco N., Mascarell L., Fritah S., and Ceredig R. Differential expression of regulator of G-protein signalling transcripts and in vivo migration of CD4+ naive and regulatory T cells. Immunology 115 (2005) 179-188
17. Hahtola S., Tuomela S., Elo L., Hakkinen T., Karenko L., Nedoszytko B., Heikkila H., Saarialho-Kere U., Roszkiewicz J., Aittokallio T., Lahesmaa R., and Ranki A. Th1 response and cytotoxicity genes are down-regulated in cutaneous T-cell lymphoma. Clin. Cancer Res. 12 (2006) 4812-4821
18. Munder M., Eichmann K., and Modolell M. Alternative metabolic states in murine macrophages reflected by the nitric oxide synthase/arginase balance: competitive regulation by CD4+ T cells correlates with Th1/Th2 phenotype. J. Immunol. 160 (1998) 5347-5354
19. Nishimura M., Umehara H., Nakayama T., Yoneda O., Hieshima K., Kakizaki M., Dohmae N., Yoshie O., and Imai T. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+ cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J. Immunol. 168 (2002) 6173-6180
20. Ueha S., Murai M., Yoneyama H., Kitabatake M., Imai T., Shimaoka T., Yonehara S., Ishikawa S., and Matsushima K. Intervention of MAdCAM-1 or fractalkine alleviates graft-versus-host reaction associated intestinal injury while preserving graft-versus-tumor effects. J. Leukoc. Biol. 81 (2007) 176-185
21. Serody J.S., Burkett S.E., Panoskaltsis-Mortari A., Ng-Cashin J., McMahon E., Matsushima G.K., Lira S.A., Cook D.N., and Blazer B.R. T-lymphocyte production of macrophage inflammatory protein-1alpha is critical to the recruitment of CD8(+) T cells to the liver, lung, and spleen during graft-versus-host disease. Blood 96 (2000) 2973-2980
22. Yakoub-Agha I., Saule P., Depil S., Micol J.B., Grutzmacher C., Boulanger-Villard F., Bauters F., Jouet J.P., Dessaint J.P., and Labalette M. A high proportion of donor CD4+ T cells expressing the lymph node-homing chemokine receptor CCR7 increases incidence and severity of acute graft-versus-host disease in patients undergoing allogeneic stem cell transplantation for hematological malignancy. Leukemia 20 (2006) 1557-1565
23. Sokol J.P., and Schiemann W.P. Cystatin C antagonizes transforming growth factor beta signaling in normal and cancer cells. Mol. Cancer Res. 2 (2004) 183-195
24. Barry M., and Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat. Rev. Immunol. 2 (2002) 401-409
25. Jaksch M., Uzunel M., Martinez Cangana G., Remberger M., and Mattsson J. Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantation. Bone Marrow Transplant. 31 (2003) 183-190
26. high regulatory T cells in human peripheral blood. J. Immunol. 167 (2001) 1245-1253
27. Condomines M., Quittet P., Lu Z.Y., Nadal L., Latry P., Lopez E., Baudard M., Requirand G., Duperray C., Schved J.F., Rossi J.F., Tarte K., and Klein B. Functional regulatory T cells are collected in stem cell autografts by mobilization with high-dose cyclophosphamide and granulocyte colony-stimulating factor. J. Immunol. 176 (2006) 6631-6639
28. Singh S.P., Zhang H.H., Foley J.F., Hedrick M.N., and Farber J.M. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J. Immunol. 180 (2008) 214-221
29. Liu H., and Rohowsky-Kochan C. Regulation of IL-17 in human CCR6+ effector memory T cells. J. Immunol. 180 (2008) 7948-7957
30. Amariglio N., Jacob-Hirsch J., Shimoni A., Leiba M., Rechavi G., and Nagler A. Changes in gene expression pattern following granulocyte colony-stimulating factor administration to normal stem cell sibling donors. Acta Haematol. 117 (2007) 68-73
31. Rogge L., Bianchi E., Biffi M., Bono E., Chang S.Y., Alexander H., Santini C., Ferrari G., Sinigaglia L., Seiler M., Neeb M., Mous J., Sinigaglia F., and Certa U. Transcript imaging of the development of human T helper cells using oligonucleotide arrays. Nat. Genet. 25 (2000) 96-101
32. Grenningloh R., Kang B.Y., and Ho I.C. Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses. J. Exp. Med. 201 (2005) 615-626
33. Song X.T., Evel-Kabler K., Shen L., Rollins L., Huang X.F., and Chen S.Y. A20 is an antigen presentation attenuator, and its inhibition overcomes regulatory T cell-mediated suppression. Nat. Med. 14 (2008) 258-265
34. Franzke A. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev. 17 (2006) 235-244
35. Jun H.X., Jun C.Y., and Yu Z.X. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 89 (2004) 1517-1524
36. Tayebi H., Kuttler F., Saas P., Lienard A., Petracca B., Lapierre V., Ferrand C., Fest T., Cahn J., Blaise D., Kuentz M., Herve P., Tiberghien P., and Robinet E. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp. Hematol. 29 (2001) 458-470
37. Zou L., Barnett B., Safah H., Larussa V.F., Evdemon-Hogan M., Mottram P., Wei S., David O., Curiel T.J., and Zou W. Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res. 64 (2004) 8451
38. Chen X., Vodanovic-Jankovic S., Johnson B., Keller M., Komorowski R., and Drobyski W.R. Absence of regulatory T-cell control of Th1 and Th17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease. Blood 110 (2007) 3804-3813
39. Zavala F., Abad S., Ezine S., Taupin V., Masson A., and Bach J.F. G-CSF therapy of ongoing experimental allergic encephalomyelitis via chemokine- and cytokine-based immune deviation. J. Immunol. 168 (2002) 2011-2019
40. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13 (2007) 139-145
41. Kared H., Masson A., Adle-Biassette H., Bach J.F., Chatenoud L., and Zavala F. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes 54 (2005) 78-84
42. Tonges L., Schlachetzki J.C., Weishaupt J.H., and Bahr M. Hematopoietic cytokines-on the verge of conquering neurology. Curr. Mol. Med. 7 (2007) 157-170
43. Ince H., and Nienaber C.A. Granulocyte-colony-stimulating factor in acute myocardial infarction: future perspectives after FIRSTLINE-AMI and REVIVAL-2. Nat. Clin. Pract. Cardiovasc. Med. 4 Suppl 1 (2007) S114-118